GB0411411D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0411411D0
GB0411411D0 GB0411411A GB0411411A GB0411411D0 GB 0411411 D0 GB0411411 D0 GB 0411411D0 GB 0411411 A GB0411411 A GB 0411411A GB 0411411 A GB0411411 A GB 0411411A GB 0411411 D0 GB0411411 D0 GB 0411411D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0411411A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0411411A priority Critical patent/GB0411411D0/en
Publication of GB0411411D0 publication Critical patent/GB0411411D0/en
Application status is Ceased legal-status Critical

Links

GB0411411A 2004-05-21 2004-05-21 Vaccines Ceased GB0411411D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0411411A GB0411411D0 (en) 2004-05-21 2004-05-21 Vaccines

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
GB0411411A GB0411411D0 (en) 2004-05-21 2004-05-21 Vaccines
RU2006139424/15A RU2006139424A (en) 2004-05-21 2005-05-19 Vaccines
KR1020067025212A KR20070029730A (en) 2004-05-21 2005-05-19 Vaccines
CA 2564778 CA2564778A1 (en) 2004-05-21 2005-05-19 Vaccines
JP2007517101A JP2007538044A (en) 2004-05-21 2005-05-19 Vaccine
BRPI0511185 BRPI0511185A (en) 2004-05-21 2005-05-19 vaccine composition, use of subunit b of a shiga toxin or an immunologically functional equivalent thereof and an antigen and an adjuvant, and process for producing a vaccine
EP05751697A EP1761275A2 (en) 2004-05-21 2005-05-19 Adjuvanted shiga toxin b-subunit based vaccines
US11/569,177 US20080069832A1 (en) 2004-05-21 2005-05-19 Vaccines
MXPA06013386A MXPA06013386A (en) 2004-05-21 2005-05-19 Vaccines.
AU2005244615A AU2005244615A1 (en) 2004-05-21 2005-05-19 Vaccines
CN 200580016322 CN1956729A (en) 2004-05-21 2005-05-19 Vaccines
PCT/EP2005/005555 WO2005112991A2 (en) 2004-05-21 2005-05-19 Vaccines
IL17889006A IL178890D0 (en) 2004-05-21 2006-10-26 Vaccines
ZA200609500A ZA200609500B (en) 2004-05-21 2006-11-15 Adjuvanted Shiga toxin B-subunit based vaccines
NO20065304A NO20065304L (en) 2004-05-21 2006-11-20 vaccinations
MA29491A MA28609B1 (en) 2004-05-21 2006-11-28 vaccines

Publications (1)

Publication Number Publication Date
GB0411411D0 true GB0411411D0 (en) 2004-06-23

Family

ID=32607764

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0411411A Ceased GB0411411D0 (en) 2004-05-21 2004-05-21 Vaccines

Country Status (16)

Country Link
US (1) US20080069832A1 (en)
EP (1) EP1761275A2 (en)
JP (1) JP2007538044A (en)
KR (1) KR20070029730A (en)
CN (1) CN1956729A (en)
AU (1) AU2005244615A1 (en)
BR (1) BRPI0511185A (en)
CA (1) CA2564778A1 (en)
GB (1) GB0411411D0 (en)
IL (1) IL178890D0 (en)
MA (1) MA28609B1 (en)
MX (1) MXPA06013386A (en)
NO (1) NO20065304L (en)
RU (1) RU2006139424A (en)
WO (1) WO2005112991A2 (en)
ZA (1) ZA200609500B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012108A (en) 2005-03-31 2007-12-05 Glaxosmithkline Biolog Sa Vaccines against chlamydial infection.
PT2457926E (en) 2005-04-29 2014-11-25 Glaxosmithkline Biolog Sa Novel method for preventing or treating m. tuberculosis infection
CA2608979A1 (en) * 2005-05-19 2006-11-23 Glaxosmithkline Biologicals S.A. Vaccine composition comprising b-subunit of e. coli heat toxin and an antigen and an adjuvant
GB0524409D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
GB0524408D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
WO2007133573A1 (en) * 2006-05-09 2007-11-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Hiv-1 immunogenic compositions
UY31101A1 (en) 2007-05-24 2009-01-05 Glaxosmithkline Biologicals Sa Lyophilised antigenic composition
EP1938836A1 (en) 2006-12-28 2008-07-02 Universite Rene Descartes (Paris V) Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells
GB0724357D0 (en) * 2007-12-14 2008-01-23 Glaxosmithkline Biolog Sa Method for preparing protein conjugates
WO2009126819A1 (en) * 2008-04-09 2009-10-15 Advanced Immune Therapeutics, Inc. Methods for improving the bioactivity of therapeutic ige antibodies for the treatment of disease
JP2012523379A (en) 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン Immunogenic compositions and uses thereof
AU2009344150B2 (en) * 2009-04-09 2014-10-09 Innavac Pty Ltd Immunogenic composition and uses thereof
GB0910045D0 (en) * 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions
GB0910046D0 (en) * 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions
AR077636A1 (en) 2009-07-08 2011-09-14 Abbott Biologicals Bv Viral vaccine and use thereof
DE102009056884A1 (en) 2009-12-03 2011-06-09 Novartis Ag Vaccine adjuvants and improved methods of making the same
USRE46906E1 (en) 2009-12-03 2018-06-26 Novartis Ag Methods for producing vaccine adjuvants
KR101616735B1 (en) 2009-12-03 2016-04-29 노파르티스 아게 Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056883B4 (en) * 2009-12-03 2012-08-16 Novartis Ag Vaccine adjuvants and improved methods of making the same
PL2356983T3 (en) * 2009-12-03 2013-08-30 Novartis Ag Circulation of components during homogenization of emulsions
CA2811957C (en) 2010-09-22 2019-04-16 The University Of Melbourne Soluble tlr2 moiety for use in the treatment or prevention of respiratory conditions associated with infectious agents
WO2012080369A1 (en) 2010-12-14 2012-06-21 Glaxosmithkline Biologicals S.A. Mycobacterium antigenic composition
CN102161998B (en) * 2011-01-14 2013-01-09 中国人民解放军军事医学科学院附属医院 Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof
GB201106357D0 (en) 2011-04-14 2011-06-01 Pessi Antonello Composition and uses thereof
EA201391790A1 (en) * 2011-07-22 2014-06-30 Глаксосмитклайн Байолоджикалс С.А. Clean prame
EP2666785A1 (en) 2012-05-23 2013-11-27 Affiris AG Complement component C5a-based vaccine
EP2703483A1 (en) 2012-08-29 2014-03-05 Affiris AG PCSK9 peptide vaccine
JP5931113B2 (en) * 2014-04-08 2016-06-08 ザ ユニバーシティー オブ メルボルン Immunogenic compositions and uses thereof
TW201623329A (en) 2014-06-30 2016-07-01 亞佛瑞司股份有限公司 Vaccines and monoclonal antibodies targeting truncated variants of osteopontin and uses thereof
EP3551222A1 (en) * 2016-12-07 2019-10-16 GlaxoSmithKline Biologicals SA Novel process
KR101966346B1 (en) * 2017-01-13 2019-04-05 전북대학교 산학협력단 Method for preparing shiga toxin Stx2e and vaccine composition for preventing porcrine edema disease comprising thereof
KR101987851B1 (en) 2017-04-28 2019-06-11 한국생명공학연구원 Animal model for age-related macular degeneration using shiga toxin type 1 B-subunit derived from Enterohamorrhagic Escherichia coli. and the screening method using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG49909A1 (en) * 1992-06-25 1998-06-15 Smithkline Beecham Biolog Vaccine composition containing adjuvants
EP0817647A4 (en) * 1995-03-24 2002-10-30 Promega Corp Treatment for verotoxin-producing escherichia coli
GB9711990D0 (en) * 1997-06-11 1997-08-06 Smithkline Beecham Biolog Vaccine
EP1078007B1 (en) * 1998-05-15 2005-11-23 Institut Curie Verotoxin b subunit for immunization
CA2370697C (en) * 1999-04-19 2012-03-06 Smithkline Beecham Biologicals S.A. Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
EP1229045A1 (en) * 2001-02-01 2002-08-07 Centre National De La Recherche Scientifique Universal carrier for targeting molecules to Gb3 receptor expressing cells

Also Published As

Publication number Publication date
BRPI0511185A (en) 2007-12-04
KR20070029730A (en) 2007-03-14
CA2564778A1 (en) 2005-12-01
RU2006139424A (en) 2008-06-27
US20080069832A1 (en) 2008-03-20
IL178890D0 (en) 2007-03-08
WO2005112991A3 (en) 2006-03-30
EP1761275A2 (en) 2007-03-14
AU2005244615A1 (en) 2005-12-01
CN1956729A (en) 2007-05-02
NO20065304L (en) 2006-11-20
ZA200609500B (en) 2008-02-27
MA28609B1 (en) 2007-05-02
WO2005112991A2 (en) 2005-12-01
JP2007538044A (en) 2007-12-27
MXPA06013386A (en) 2007-01-23

Similar Documents

Publication Publication Date Title
TWI346544B (en) Knochenschraube
IL241732A (en) 2-di-tert-butyloxycarbonylamino-6-bromo-9-(2-trimehylsilylethoxy)methyl-9h-purine
GB0426736D0 (en) MyFone
SI1802198T1 (en) Synergistische fungizide Zusammensetzungen
DE602005003960D1 (en) Oximesther-fotoinitiatoren
DE602005017576D1 (en) Wirbel-osteosynthese-gerät
DE602005025924D1 (en) Royl-coa-desaturase
EP1769743A4 (en) Radiotomograph
IL178884A (en) Cis-imidazolines
DE602005022165D1 (en) Fluidleitungsverbindervorrichtung
DE602005025220D1 (en) Thernet-kabel
DE602005003667D1 (en) Sandwich-hybridmontagematte
DE602005020252D1 (en) Röhrenförmige prothese
EP1804831A4 (en) Listeria-based and llo-based vaccines
TWI365191B (en) Vaccine
SI1968631T1 (en) Vaccine
DE502005007844D1 (en) Phasenstabile polyurethanprepolymere
TWI346750B (en) Planetenradgetriebe
RU2006139424A (en) Vaccines
IL182983D0 (en) 4-hydroxybenzomorphans
DE602005007474D1 (en) Substituierte morpholin- und thiomorpholinderivate
DE602005010905D1 (en) Roboterhandvorrichtung
PL1593299T3 (en) Rotobaler
ZA200700942B (en) Compressor-distractor
DE602005018033D1 (en) Luftreinigungsvorrichtung

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)